2003

The US Food and Drug Administration (FDA) grants the primary Lipogen ingredient phosphatidylserine (PS) a Qualified Health Claim approval, allowing Lipogen to specify on its label that consumption of PS “may reduce the risk of dementia or cognitive dysfunction in the elderly.”

In 2019, PS is still the only nutritional supplement that has this claim approval (in the proper dose), while other supplement-claim requests have been rejected by the FDA.